Literature DB >> 7724175

Penetrating keratoplasty in cicatrizing conjunctival diseases.

I Tugal-Tutkun1, Y A Akova, C S Foster.   

Abstract

PURPOSE: The outcome of successful penetrating keratoplasty (PK) typically is poor in eyes with end-stage chronic cicatrizing conjunctival diseases such as ocular cicatricial pemphigoid (OCP), Stevens-Johnson syndrome, and toxic epidermal necrolysis due to immunologically driven conjunctival inflammation associated with conjunctival cicatrization and lid abnormalities, severe dry eye, and extensive corneal neovascularization. The authors report the results of their experience with PK in 13 patients with OCP, Stevens-Johnson syndrome, and toxic epidermal necrolysis.
METHODS: The authors reviewed the records of patients with OCP, Stevens-Johnson syndrome, or toxic epidermal necrolysis seen between 1976 and 1992. Patients who underwent PK were examined for the purpose of this study. Initial and final visual acuity, indications for PK, surgical procedure, postoperative therapy, complications, total number of repeat PKs, length of follow-up, and the final outcome were recorded.
RESULTS: Thirty-two PKs were performed in 16 eyes of 13 patients with advanced OCP (6 patients), OCP as a sequela of Stevens-Johnson syndrome (2 patients), Stevens-Johnson syndrome (3 patients), and toxic epidermal necrolysis (2 patients). The indications for the first PK were corneal perforation in six eyes (37.5%) and extensive corneal scarring in ten eyes (62.5%). Preoperative visual acuity was counting fingers in five eyes, hand motions in eight, and light perception in three. Preoperative therapy included systemic chemotherapy (8 patients), mucous membrane grafting (9 eyes), lamellar keratoplasty (2 eyes), superficial keratectomy (1 eye), and corneal dye laser photocoagulation (6 eyes). The mean follow-up period was 4.6 years (3 months-13 years). Eight eyes (50%) had clear grafts, and three eyes (18.7%) had 20/200 or better visual acuity at last visit. The major causes of graft failure were epithelial defect formation/persistence, stromal ulceration, perforation, and graft rejection.
CONCLUSIONS: These results indicate that PK may be performed for tectonic reasons, but prospects for restoration of sight in patients with advanced cicatrizing conjunctival diseases, even after extensive preoperative medical and surgical therapy, are limited.

Entities:  

Mesh:

Year:  1995        PMID: 7724175     DOI: 10.1016/s0161-6420(95)30980-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  24 in total

1.  Boston type 1 keratoprosthesis: the New York Eye and Ear experience.

Authors:  A P Patel; E I Wu; D C Ritterband; J A Seedor
Journal:  Eye (Lond)       Date:  2011-12-16       Impact factor: 3.775

Review 2.  Autoimmune bullous diseases: ocular manifestations and management.

Authors:  Caroline Laforest; Shyamala C Huilgol; Robert Casson; Dinesh Selva; Igal Leibovitch
Journal:  Drugs       Date:  2005       Impact factor: 9.546

3.  Cost effectiveness of the type II Boston keratoprosthesis.

Authors:  J D Ament; T P Stryjewski; S Pujari; S Siddique; G N Papaliodis; J Chodosh; C H Dohlman
Journal:  Eye (Lond)       Date:  2010-12-24       Impact factor: 3.775

Review 4.  Graft failure: II. Ocular surface complications.

Authors:  Samar A Al-Swailem
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

5.  Iatrogenic limbal stem cell deficiency.

Authors:  E J Holland; G S Schwartz
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Epithelial transplantation for the management of severe ocular surface disease.

Authors:  E J Holland
Journal:  Trans Am Ophthalmol Soc       Date:  1996

7.  High-resolution spectral domain anterior segment optical coherence tomography in type 1 Boston keratoprosthesis.

Authors:  Brett L Shapiro; Dennis E Cortés; Eric K Chin; Jennifer Y Li; John S Werner; Ellen Redenbo; Mark J Mannis
Journal:  Cornea       Date:  2013-07       Impact factor: 2.651

8.  Neutrophil collagenase, gelatinase, and myeloperoxidase in tears of patients with stevens-johnson syndrome and ocular cicatricial pemphigoid.

Authors:  Samer N Arafat; Ana M Suelves; Sandra Spurr-Michaud; James Chodosh; C Stephen Foster; Claes H Dohlman; Ilene K Gipson
Journal:  Ophthalmology       Date:  2013-08-17       Impact factor: 12.079

Review 9.  [Mucous membrane pemphigoid with ocular involvement. Part II: therapy].

Authors:  T Meyer-ter-Vehn; E Schmidt; D Zillikens; G Geerling
Journal:  Ophthalmologe       Date:  2008-04       Impact factor: 1.059

10.  Th1- and Th2-related chemokine and chemokine receptor expression on the ocular surface in endotoxin-induced uveitis.

Authors:  Liem Trinh; Françoise Brignole-Baudouin; Aude Pauly; Hong Liang; Marianne Houssier; Christophe Baudouin
Journal:  Mol Vis       Date:  2008-12-19       Impact factor: 2.367

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.